Evidence map›Paper›PMID 22032985›Full record

ReviewTrends in pharmacological sciences2012

Drug targets: single-cell transcriptomics hastens unbiased discovery.

Tamas Bartfai, Peter T Buckley, James Eberwine

Abstract readReview
In one paragraph

Review in Trends in pharmacological sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Depression-like behavior in rat: Involvement of galanin receptor subtype 1 in the ventral periaqueductal gray.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  5. Article
  6. Review
  7. Serotonergic neuron regulation informed by in vivo single-cell transcriptomics.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
  8. Review
  9. Article
  10. Article
  11. Quantitative biology of single neurons.Journal of the Royal Society, Interface · 2012
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tamas BartfaiMolecular and Integrative Neurosciences Department, The Scripps Research Institute, 10 550N. Torrey Pines Road, SR307, La Jolla, CA, 92037, USA. tbartfai@scripps.edu
Peter T Buckley
James Eberwine

Funding

Gene expression in single aging neurons and gliaR37AG009900 · NIA · UNIVERSITY OF PENNSYLVANIA · PI EBERWINE, JAMES H · 2001 to 2010
$3.4M
Developing GalR1/2 Agonists to Treat Nerve Gas Induced SeizureU01NS063560 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI BARTFAI, TAMAS · 2008 to 2010
$2.8M
Single-cell comparative genomics of the neuronR01MH088849 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI EBERWINE, JAMES H, KIM, JUNHYONG · 2009 to 2012
$1.2M
GENE EXPRESSION IN SINGLE AGING NEURONS AND GLIAR01AG009900 · NIA · UNIVERSITY OF PENNSYLVANIA · PI EBERWINE, JAMES H · 1991 to 2000
$310k
INCREASING BREAST AND CERVICAL CANCER SCREENING RATES IN LO-INCOME, RURAL, HISPANU58DP004117 · DP · NEBRASKA ST DEPT OF HEALTH & HUMAN SERVS · PI LEYPOLDT, MELISSA D · 2012 to 2012
$195k
NCCDPHP CDC HHS DP10D004117NIA NIH HHS AG9900NIA NIH HHS R01 AG009900NIA NIH HHS R37 AG009900NIMH NIH HHS MH88849,NIMH NIH HHS R01 MH088849NINDS NIH HHS U01 NS063560
6 · The paper itself

Abstract

Drug discovery in neuro- and psychopharmacology is lagging, and the most commonly mentioned cause is the scarcity of drug targets. Using NextGen 'sequencing based single-cell transcriptomics' (SBSCT), several hundred different receptors and channels can be identified in individual neurons, and the functional gene product can subsequently be validated. The use of single-cell transcriptome data to reveal the entire receptor repertoire is crucial, as the copy numbers of mRNAs encoding receptors are low, and when cells are pooled dilution of rare mRNAs leads to loss of signal. These overlooked receptors on key neurons often mediate robust effects that may be therapeutically useful. SBSCT also enables the identification of orphan receptors and can provide strong evidence for receptor heterodimers. Here, we compare SBSCT to other single-cell profiling methods. We argue that the unbiased nature of SBSCT makes it a powerful tool for the identification of new drug targets.

Indexed as

Drug DesignAnimalsGene Expression ProfilingOrphan Nuclear ReceptorsOrphan Nuclear Receptors

Identifiers

PMID22032985
PMCPMC3259260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.